Skip to main content
. 2021 Aug 2;13(15):3902. doi: 10.3390/cancers13153902

Figure 4.

Figure 4

Data collection and analyses per patient in PANFIRE-III. Biopsies from primary (P) and metastatic (M) tissue will be analyzed using flow cytometry, histopathology/immunohistochemistry (IHC), and proteomics. Blood samples will be analyzed using flow cytometry. Imaging will be performed by ceCT, FDG (18F-FDG) PET-CT, and PD-L1 (18F-BMS-986192) PET-CT. Pain scores and quality of life scores will be evaluated by validated questionnaires.